Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. 4 Open-market sale Chief Business Officer sold 2,491 shares at $13.39 ($33,360)
  2. 4 Open-market sale Chief Financial Officer sold 1,428 shares at $13.39 ($19,124)
  3. 4 Open-market sale Chief Scientific Officer sold 1,907 shares at $13.39 ($25,539)
  4. 4 Open-market sale President and CEO sold 7,972 shares at $13.39 ($106,764)
  5. 4 Open-market sale CMO sold 2,862 shares at $13.39 ($38,329)
  6. 4 Grant or award Director acquired 858 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Chief Scientific Officer sold 1,551 shares at $16.45 ($25,520)
  14. 4 Open-market sale General Counsel sold 1,930 shares at $16.45 ($31,757)
  15. 4 Open-market sale President and CEO sold 4,276 shares at $16.45 ($70,358)
  16. 4 Open-market sale CMO sold 5,187 shares at $16.45 ($85,348)
  17. 4 Open-market sale Chief Business Officer sold 1,691 shares at $16.45 ($27,824)
  18. 4 Open-market sale Chief Financial Officer sold 1,314 shares at $16.45 ($21,621)
  19. 4 Open-market buy Director bought 496,771 shares at $20.13 ($10,000,000)
  20. 4 Open-market buy Director bought 496,771 shares at $20.13 ($10,000,000)

Page 3 of 11 · 203 filings